Apomorphine has a rich history that spans nearly two centuries. It was first created in 1845. In 2025, it will be 180 years since its first documented synthesis. In 2023, the U. S. Food and Drug Administration (FDA) approved a new device for treating advanced Parkinson's disease. This device delivers apomorphine under the skin. Many people have misunderstood apo...